Search by Ticker
The following stock analysis is based on 9.8 years of data (i.e. since May 20, 2013). All the stock history has been downloaded.
Illumina trades on the NasdaqGS exchange in USD dollars.
It is in the sector.
It is currently trading at $221.905 ($219.77 the previous day).
The next reporting date is in 34 days (2023 04 25).
CNN estimates profits for the upcoming quarter will be $0.03 per share ($1.1B). The current Canada / US exchange rate is 1.36678.
Over the past 12 months, $0 worth of shares have been purchased and $4931375 worth of shares have been sold by insiders.
The year over year average increase is -2.3% per year assuming steady exponential growth. The actual 5 year average is 7.42. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||223.18253164557||-45.9||- Below Average|
|2 year||412.56946376812||13.7||+ Above Average|
|3 year||362.75621794872||17.3||+ Above Average|
|4 year||309.1928716129||2.8||- Below Average|
|5 year||300.77882129278||49.2||+ Above Average|
The worst drop it has had in recent years is -64.5%. It has a shape to the stock curve, which means
SandP 500 Losers: First Republic Crashes; Dow Giant Microsoft SlidesMon, 20 Mar 2023 20:33:13 First Republic is the new bank crisis epicenter, with FRC stock easily the SandP 500's biggest loser Monday. Microsoft fell below a buy point.... Read Full Article
Illumina Underscores Commitment to Shareholder Value and Responds to Carl Icahn's StatementsMon, 20 Mar 2023 11:30:00 Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response to Carl Icahn's public statements and letters to Illumina's shareholders dated March 13 and March 15, 2023:... Read Full Article
Illumina Should Heed Carl Icahn, Give Up on GrailFri, 17 Mar 2023 18:31:00 Many of Illumina shareholders have grown increasingly frustrated with Chief Executive Francis deSouza’s pursuit of Grail. The decision to close the $7.1 billion acquisition in August 2021 despite regulators’ objections baffled many investors and is largely to blame for cutting the ...... Read Full Article
Why Is Seattle Genetics (SGEN) Up 24.6% Since Last Earnings Report?Fri, 17 Mar 2023 15:30:03 Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.... Read Full Article
UPDATE 1-Carl Icahn urges Fed to keep fighting inflation after SVB collapse - FTFri, 17 Mar 2023 04:45:03 Activist investor Carl Icahn has urged the U.S. Federal Reserve to stay the course in the fight against the "disease of inflation" despite the failure of Silicon Valley Bank and two other banks last week, the Financial Times reported ...... Read Full Article
Carl Icahn urges Fed to keep fighting inflation ‘disease’ after SVB collapseFri, 17 Mar 2023 04:00:04 Activist investor Carl Icahn has urged the Federal Reserve to stay the course in the fight against the “disease of inflation” despite the failure of Silicon Valley Bank and two other banks last week. “I think you have to stamp ...... Read Full Article
Buy This Magnificent Growth Stock Before It's Too LateThu, 16 Mar 2023 13:57:00 Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential. Bionano's claim to fame is ...... Read Full Article
Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fightWed, 15 Mar 2023 18:51:58 In his second letter to Illumina shareholders this week, Icahn wrote the "only path forward is for Grail to be divested". Illumina said on Monday it will divest Grail, which it purchased in 2021, if it loses its appeal to the ...... Read Full Article
Illumina (ILMN) Unveils Complete Long Reads TechnologyWed, 15 Mar 2023 17:25:05 Illumina's (ILMN) Complete Long Read Prep combines Illumina sequencing by synthesis chemistry with DRAGEN secondary analysis to provide WGS with more accuracy.... Read Full Article
Illumina launches its first product enabling long- and short-read sequencing on one instrumentWed, 15 Mar 2023 00:00:00 Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to order. The high-performance, long-read, human whole-genome sequencing (WGS) ...... Read Full Article
Company News for Mar 14, 2023Tue, 14 Mar 2023 13:24:01 Companies In The News Are: SGEN, PFE, PODD, SIVB, ILMN, PNC.... Read Full Article
SVB May Be a Failure of Supervision. What It Means for Other Banks.Tue, 14 Mar 2023 10:47:00 Pfizer bets $43 billion on Seagen, United Airlines projects loss on reduced demand, March Madness to draw $15.5 billion in wagers, and other news to start your day.... Read Full Article
Illumina Surges As Activist Investor Carl Icahn Attempts To Wrest ControlMon, 13 Mar 2023 22:01:19 Activist investor Carl Icahn is fighting for control of Illumina after the acquisition of Grail. In response, ILMN stock surged Monday.... Read Full Article
These Stocks Are Moving the Most Today: First Republic, Schwab, Seagen, Provention Bio, Illumina, and MoreMon, 13 Mar 2023 20:16:00 First Republic shares sink even as the bank received funding from JPMorgan Chase and the Federal Reserve, Pfizer announces it will acquire Seagen for $43 billion, and Provention Bio soars after agreeing to be acquired by France's Sanofi in a $2.9 billion ...... Read Full Article
Carl Icahn takes aim at genome sequencer Illumina over Grail dealMon, 13 Mar 2023 18:53:15 Shares in Illumina surged more than 20 per cent on Monday following a decision by activist investor Carl Icahn to launch a proxy battle over what he described as the company’s “reckless” acquisition of cancer-screening start-up Grail. Icahn sent a ...... Read Full Article
Illumina: It’s not in the ‘best interests’ of shareholders to support Carl Icahn’s nominees to the boardMon, 13 Mar 2023 18:43:00 Illumina Inc. (ILMN) said Monday it received notice from Icahn Partners that the organization plans to nominate three candidates to to the board over concerns about the company’s $7.1 billion acquisition of Grail. Jesse Lynn and Andrew Teno are current ...... Read Full Article
Illumina Responds to Icahn Partners' Nomination of DirectorsMon, 13 Mar 2023 17:47:00 Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, ...... Read Full Article
Carl Icahn Takes Aim at Illumina Over Grail DealMon, 13 Mar 2023 17:45:00 Carl Icahn said in a letter to Illumina shareholders that he plans to nominate three people to the biotech's board.... Read Full Article
Icahn launches proxy fight at Illumina, seeks board seatsMon, 13 Mar 2023 15:05:51 (Reuters) -Billionaire investor Carl Icahn is pushing for three board seats at Illumina, criticizing the biotechnology company's acquisition of a cancer test developer that cost investors $50 billion. Icahn, who owns 1.4% of Illumina, told other investors in a letter on Monday ...... Read Full Article
Why Illumina Shares Are Soaring Today?Mon, 13 Mar 2023 15:04:25 Billionaire activist Carl Icahn is preparing a proxy fight at Illumina Inc (NASDAQ: ILMN), saying the company went ahead with the controversial acquisition of Grail Inc despite opposition from regulators, costing shareholders $50 billion. According to the letter viewed by Wall ...... Read Full Article